ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
$224.41
arrow_upward
+0.21%(+0.47) 1D
$224.41
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNY...
Open
$224.39
High
$230.42
Low
$222.46
Mkt. cap
30.03B
Avg. vol.
1.50M
Volume
0.00
P/E ratio
38.19
52-wk high
$495.55
52-wk low
$197.81
EPS
$5.88
Beta
0.28
Shares outstanding
133.81M
No. of employees
2K
Open
$224.39
High
$230.42
Low
$222.46
Mkt. cap
30.03B
Avg. vol.
1.50M
Volume
0.00
P/E ratio
38.19
52-wk high
$495.55
52-wk low
$197.81
EPS
$5.88
Beta
0.28
Shares outstanding
133.81M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
2 hours ago
Alnylam Pharmaceuticals stock gets a Strong Buy upgrade from Zacks Research
Zacks
·
15 hours ago
ETON Stock Surges 108% in Six Months: Here's What You Need to Know
Trefis
·
2 days ago
Alnylam Pharmaceuticals Stock: 5 Straight Red Days, Down 14%
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals, Inc.